was successfully added to your cart.

Cart

Cannabis Legislation

WHO Recommends CBD’s Removal from Drug Schedule

By September 11, 2018 September 20th, 2019 No Comments
image of the globe captioned "who recommends CBD's removal from Drug Schedule"

In June 2018, the World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD) stated that cannabidiol should not be included on the International Drug Control Conventions’ schedule of addictive substances.

The ECDD’s June report expands on their December 2017 recommendation that cannabidiol should no longer appear on international controlled substance schedules.

[CBD is] generally well-tolerated, with a good safety profile,” the report says.

Hemp CBD is cultivated to contain 0.03% THC or less and is non-psychotropic. It’s a popular ingredient in foods, dietary supplements, cosmetics, and body care products worldwide.

Regarding CBD’s inclusion on international schedules, the WHO states, “[…] CBD does not produce the effects that are typically seen with cannabinoids such as THC. It also failed to produce significant effects in a human study of abuse potential…”

No risk for CBD abuse, WHO says

The WHO said that, although human studies on CBD are currently limited, the data that is available from human research suggests that those who use CBD aren’t at risk for abusing it.

WHO officials indicated that there’s a clear differentiator between hemp cannabidiol and THC. They compared the effects of each compound, noting the major differences between THC and CBD.

“In experimental models of abuse liability, CBD appears to have little effect on conditioned place preference or intracranial self-stimulation,” the WHO said.

“In an animal drug discrimination model CBD failed to substitute for THC. In humans, CBD exhibits no effects indicative of any abuse or dependence potential.”

No recreational abuse or public health problems associated with CBD

Hemp CBD that contains 0.03% THC or less isn’t used recreationally and doesn’t pose the same risk as the addictive, psychoactive drugs on the controlled substances schedule.

“To date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD,” the WHO said.

If the final version of the 2018 Farm Bill, expected this fall, includes the Hemp Farm Bill language which was passed with bipartisan support by the Senate, it could permanently remove hemp from the list of controlled substances in America.

This important step would align with the WHO’s summer recommendation and with the US Department of Health and Human Services (HHS) patent #6,630,507, granted in 2003.

 

Resources:

http://www.who.int/medicines/access/controlled-substances/ecdd_40_meeting/en/
http://www.who.int/medicines/access/controlled-substances/WHOCBDReportMay2018-2.pdf?ua=1
http://www.who.int/medicines/access/controlled-substances/Cannabidiolpeerreview1.pdf?ua=1
http://www.who.int/features/qa/cannabidiol/en/
https://patents.google.com/patent/US6630507B1/en